| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| - - | HOLD | 0 @ USD 0 | USD 0 | The current share valuation price of - based on adjusted close was USD 0. The average price that - shares were previous bought at was USD 0.00279608. The current market price is -100.0% lower than average price they were purchased at. USD 0 compared to the previous valuation of however if the holding was sold on 2025-12-17 this would crystalise an overall loss. |
| 182400.KQ - NKMAX LTD | HOLD | 0 @ KRW 3.89052 | KRW 0 | |
| MRUS - Merus BV | HOLD | 0 @ USD 96.89 | USD 0 | The current share valuation price of MRUS based on adjusted close was USD 96.89. The average price that MRUS shares were previous bought at was USD 56.564. The current market price is 71.3% higher than average price they were purchased at. The value of the holding in MRUS has fallen by USD 2,323 compared to the previous valuation of Merus BV |
| ARCT - Arcturus Therapeutics Holdings Inc | SELL | -124 @ USD 6.52 | USD -808 | The ETF sold 124 shares of ARCT on 2025-12-17. The shares were previously bought for an average price of USD 13.0207. The Arcturus Therapeutics Holdings Inc shares were sold for -49.9% lower than average price of previous purchases. This resulted in an overall loss of USD 806 The average price that the ETF previously sold ARCT share for is USD 13.1472 which is higher than the selling price of USD 6.52 on 2025-12-17. |
| 4974.T - Takara Bio Inc. | SELL | -300 @ JPY 4.96059 | JPY -1,488 | The ETF sold 300 shares of 4974.T on 2025-12-17. The shares were previously bought for an average price of JPY 5.75157. The Takara Bio Inc. shares were sold for -13.8% lower than average price of previous purchases. This resulted in an overall loss of JPY 237 (USD $2) The average price that the ETF previously sold 4974.T share for is JPY 5.82733 which is higher than the selling price of JPY 4.96059 on 2025-12-17. |
| 4549.T - Eiken Chemical Co., Ltd. | SELL | -100 @ JPY 15.4801 | JPY -1,548 | The ETF sold 100 shares of 4549.T on 2025-12-17. The shares were previously bought for an average price of JPY 13.728. The Eiken Chemical Co., Ltd. shares were sold for 12.8% higher than average price of previous purchases. This sale made a profit of JPY 175 (USD $1) The average price that the ETF previously sold 4549.T share for is JPY 14.3332 so the ETF has sold 100 shares on 2025-12-17 at a higher price than the previous selling average. |
| SLP - Sylvania Platinum Limited | SELL | -84 @ USD 18.7 | USD -1,571 | The ETF sold 84 shares of SLP on 2025-12-17. The shares were previously bought for an average price of USD 26.1345. The Sylvania Platinum Limited shares were sold for -28.4% lower than average price of previous purchases. This resulted in an overall loss of USD 624 The average price that the ETF previously sold SLP share for is USD 27.004 which is higher than the selling price of USD 18.7 on 2025-12-17. |
| VNDA - Vanda Pharmaceuticals Inc | SELL | -309 @ USD 6.82 | USD -2,107 | The ETF sold 309 shares of VNDA on 2025-12-17. The shares were previously bought for an average price of USD 4.65578. The Vanda Pharmaceuticals Inc shares were sold for 46.5% higher than average price of previous purchases. This sale made a profit of USD 669 The average price that the ETF previously sold VNDA share for is USD 4.59057 so the ETF has sold 309 shares on 2025-12-17 at a higher price than the previous selling average. |
| EVH - Evolent Health Inc | SELL | -578 @ USD 4.04 | USD -2,335 | The ETF sold 578 shares of EVH on 2025-12-17. The shares were previously bought for an average price of USD 9.55347. The Evolent Health Inc shares were sold for -57.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,187 The average price that the ETF previously sold EVH share for is USD 10.7283 which is higher than the selling price of USD 4.04 on 2025-12-17. |
| 1877.HK - SHANGHAI JUNSHI BIOSCIENCES LTD H | SELL | -800 @ HKD 2.95386 | HKD -2,363 | The ETF sold 800 shares of 1877.HK on 2025-12-17. The shares were previously bought for an average price of HKD 2.51798. The SHANGHAI JUNSHI BIOSCIENCES LTD H shares were sold for 17.3% higher than average price of previous purchases. This sale made a profit of HKD 349 (USD $45) The average price that the ETF previously sold 1877.HK share for is HKD 2.02055 so the ETF has sold 800 shares on 2025-12-17 at a higher price than the previous selling average. |
| MRVI - Maravai Lifesciences Holdings Inc | SELL | -707 @ USD 3.46 | USD -2,446 | The ETF sold 707 shares of MRVI on 2025-12-17. The shares were previously bought for an average price of USD 2.97559. The Maravai Lifesciences Holdings Inc shares were sold for 16.3% higher than average price of previous purchases. This sale made a profit of USD 342 The average price that the ETF previously sold MRVI share for is USD 3.38631 so the ETF has sold 707 shares on 2025-12-17 at a higher price than the previous selling average. |
| IBRX - Immunitybio Inc | SELL | -1,243 @ USD 2.11 | USD -2,623 | The ETF sold 1243 shares of IBRX on 2025-12-17. The shares were previously bought for an average price of USD 2.81966. The Immunitybio Inc shares were sold for -25.2% lower than average price of previous purchases. This resulted in an overall loss of USD 882 The average price that the ETF previously sold IBRX share for is USD 3.30452 which is higher than the selling price of USD 2.11 on 2025-12-17. |
| XVIVO.ST - | SELL | -133 @ SEK 19.8403 | SEK -2,639 | The ETF sold 133 shares of XVIVO.ST on 2025-12-17. The shares were previously bought for an average price of SEK 40.1806. The shares were sold for -50.6% lower than average price of previous purchases. This resulted in an overall loss of SEK 2,705 (USD $291) The average price that the ETF previously sold XVIVO.ST share for is SEK 33.17 which is higher than the selling price of SEK 19.8403 on 2025-12-17. |
| LAB - Standard Biotools Inc | SELL | -1,871 @ USD 1.55 | USD -2,900 | The ETF sold 1871 shares of LAB on 2025-12-17. The shares were previously bought for an average price of USD 1.39779. The Standard Biotools Inc shares were sold for 10.9% higher than average price of previous purchases. This sale made a profit of USD 285 The average price that the ETF previously sold LAB share for is USD 1.31813 so the ETF has sold 1871 shares on 2025-12-17 at a higher price than the previous selling average. |
| 7575.T - Japan Lifeline Co., Ltd. | SELL | -300 @ JPY 9.92118 | JPY -2,976 | The ETF sold 300 shares of 7575.T on 2025-12-17. The shares were previously bought for an average price of JPY 10.1423. The Japan Lifeline Co., Ltd. shares were sold for -2.2% lower than average price of previous purchases. This resulted in an overall loss of JPY 66 (USD $0) The average price that the ETF previously sold 7575.T share for is JPY 9.54395 so the ETF has sold 300 shares on 2025-12-17 at a higher price than the previous selling average. |
| VLA.PA - Valneva SE | SELL | -736 @ EUR 4.1799 | EUR -3,076 | The ETF sold 736 shares of VLA.PA on 2025-12-17. The shares were previously bought for an average price of EUR 2.91512. The Valneva SE shares were sold for 43.4% higher than average price of previous purchases. This sale made a profit of EUR 931 (USD $1,094) The average price that the ETF previously sold VLA.PA share for is EUR 3.1143 so the ETF has sold 736 shares on 2025-12-17 at a higher price than the previous selling average. |
| PACB - Pacific Biosciences of California | SELL | -1,620 @ USD 1.93 | USD -3,127 | The ETF sold 1620 shares of PACB on 2025-12-17. The shares were previously bought for an average price of USD 1.37661. The Pacific Biosciences of California shares were sold for 40.2% higher than average price of previous purchases. This sale made a profit of USD 896 The average price that the ETF previously sold PACB share for is USD 1.51548 so the ETF has sold 1620 shares on 2025-12-17 at a higher price than the previous selling average. |
| RGNX - Regenxbio Inc | SELL | -238 @ USD 13.17 | USD -3,134 | The ETF sold 238 shares of RGNX on 2025-12-17. The shares were previously bought for an average price of USD 8.67354. The Regenxbio Inc shares were sold for 51.8% higher than average price of previous purchases. This sale made a profit of USD 1,070 The average price that the ETF previously sold RGNX share for is USD 8.56178 so the ETF has sold 238 shares on 2025-12-17 at a higher price than the previous selling average. |
| 096530.KQ - Seegene, Inc. | SELL | -194 @ KRW 16.5906 | KRW -3,219 | The ETF sold 194 shares of 096530.KQ on 2025-12-17. The shares were previously bought for an average price of KRW 17.6933. The Seegene, Inc. shares were sold for -6.2% lower than average price of previous purchases. This resulted in an overall loss of KRW 214 (USD $0) The average price that the ETF previously sold 096530.KQ share for is KRW 20.8436 which is higher than the selling price of KRW 16.5906 on 2025-12-17. |
| RO.SW - | SELL | -8 @ CHF 411.805 | CHF -3,294 | The ETF sold 8 shares of RO.SW on 2025-12-17. The shares were previously bought for an average price of CHF 370.354. The shares were sold for 11.2% higher than average price of previous purchases. This sale made a profit of CHF 332 (USD $417) The average price that the ETF previously sold RO.SW share for is CHF 332.306 so the ETF has sold 8 shares on 2025-12-17 at a higher price than the previous selling average. |
| VIR - Vir Biotechnology Inc | SELL | -545 @ USD 6.14 | USD -3,346 | The ETF sold 545 shares of VIR on 2025-12-17. The shares were previously bought for an average price of USD 7.32775. The Vir Biotechnology Inc shares were sold for -16.2% lower than average price of previous purchases. This resulted in an overall loss of USD 647 The average price that the ETF previously sold VIR share for is USD 6.48924 which is higher than the selling price of USD 6.14 on 2025-12-17. |
| VIR - Vidrala S.A | SELL | -545 @ USD 6.14 | USD -3,346 | The ETF sold 545 shares of VIR on 2025-12-17. The shares were previously bought for an average price of USD 7.32775. The Vidrala S.A shares were sold for -16.2% lower than average price of previous purchases. This resulted in an overall loss of USD 647 The average price that the ETF previously sold VIR share for is USD 6.48924 which is higher than the selling price of USD 6.14 on 2025-12-17. |
| MYGN - Myriad Genetics Inc | SELL | -488 @ USD 6.95 | USD -3,392 | The ETF sold 488 shares of MYGN on 2025-12-17. The shares were previously bought for an average price of USD 8.64702. The Myriad Genetics Inc shares were sold for -19.6% lower than average price of previous purchases. This resulted in an overall loss of USD 828 The average price that the ETF previously sold MYGN share for is USD 10.0069 which is higher than the selling price of USD 6.95 on 2025-12-17. |
| CTKB - Cytek Biosciences Inc | SELL | -706 @ USD 4.81 | USD -3,396 | The ETF sold 706 shares of CTKB on 2025-12-17. The shares were previously bought for an average price of USD 5.7145. The Cytek Biosciences Inc shares were sold for -15.8% lower than average price of previous purchases. This resulted in an overall loss of USD 639 The average price that the ETF previously sold CTKB share for is USD 4.48609 so the ETF has sold 706 shares on 2025-12-17 at a higher price than the previous selling average. |
| DAWN - Day One Biopharmaceuticals Inc | SELL | -410 @ USD 8.76 | USD -3,592 | The ETF sold 410 shares of DAWN on 2025-12-17. The shares were previously bought for an average price of USD 8.3429. The Day One Biopharmaceuticals Inc shares were sold for 5.0% higher than average price of previous purchases. This sale made a profit of USD 171 The average price that the ETF previously sold DAWN share for is USD 7.5699 so the ETF has sold 410 shares on 2025-12-17 at a higher price than the previous selling average. |
| 328130.KQ - Lunit Inc. | SELL | -143 @ KRW 25.207 | KRW -3,605 | The ETF sold 143 shares of 328130.KQ on 2025-12-17. The shares were previously bought for an average price of KRW 36.3011. The Lunit Inc. shares were sold for -30.6% lower than average price of previous purchases. This resulted in an overall loss of KRW 1,586 (USD $1) The average price that the ETF previously sold 328130.KQ share for is KRW 35.754 which is higher than the selling price of KRW 25.207 on 2025-12-17. |
| EMBC - Embecta Corp | SELL | -308 @ USD 11.78 | USD -3,628 | The ETF sold 308 shares of EMBC on 2025-12-17. The shares were previously bought for an average price of USD 13.0183. The Embecta Corp shares were sold for -9.5% lower than average price of previous purchases. This resulted in an overall loss of USD 381 The average price that the ETF previously sold EMBC share for is USD 12.5438 which is higher than the selling price of USD 11.78 on 2025-12-17. |
| IOVA - Iovance Biotherapeutics Inc | SELL | -1,492 @ USD 2.52 | USD -3,760 | The ETF sold 1492 shares of IOVA on 2025-12-17. The shares were previously bought for an average price of USD 2.41138. The Iovance Biotherapeutics Inc shares were sold for 4.5% higher than average price of previous purchases. This sale made a profit of USD 162 The average price that the ETF previously sold IOVA share for is USD 4.73447 which is higher than the selling price of USD 2.52 on 2025-12-17. |
| EUZ.DE - Eckert & Ziegler SE | SELL | -230 @ EUR 17.2203 | EUR -3,961 | The ETF sold 230 shares of EUZ.DE on 2025-12-17. The shares were previously bought for an average price of EUR 18.7965. The Eckert & Ziegler SE shares were sold for -8.4% lower than average price of previous purchases. This resulted in an overall loss of EUR 363 (USD $426) The average price that the ETF previously sold EUZ.DE share for is EUR 28.2756 which is higher than the selling price of EUR 17.2203 on 2025-12-17. |
| ABCL - Abcellera Biologics Inc | SELL | -1,230 @ USD 3.35 | USD -4,121 | The ETF sold 1230 shares of ABCL on 2025-12-17. The shares were previously bought for an average price of USD 3.61385. The Abcellera Biologics Inc shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 325 The average price that the ETF previously sold ABCL share for is USD 2.72769 so the ETF has sold 1230 shares on 2025-12-17 at a higher price than the previous selling average. |
| KURA - Kura Oncology Inc | SELL | -417 @ USD 10.18 | USD -4,245 | The ETF sold 417 shares of KURA on 2025-12-17. The shares were previously bought for an average price of USD 10.711. The Kura Oncology Inc shares were sold for -5.0% lower than average price of previous purchases. This resulted in an overall loss of USD 221 The average price that the ETF previously sold KURA share for is USD 8.79407 so the ETF has sold 417 shares on 2025-12-17 at a higher price than the previous selling average. |
| 007390.KQ - NatureCell Co.,Ltd. | SELL | -280 @ KRW 15.3066 | KRW -4,286 | The ETF sold 280 shares of 007390.KQ on 2025-12-17. The shares were previously bought for an average price of KRW 21.4176. The NatureCell Co.,Ltd. shares were sold for -28.5% lower than average price of previous purchases. This resulted in an overall loss of KRW 1,711 (USD $1) The average price that the ETF previously sold 007390.KQ share for is KRW 18.0499 which is higher than the selling price of KRW 15.3066 on 2025-12-17. |
| JANX - Janux Therapeutics Inc | SELL | -305 @ USD 14.1 | USD -4,301 | The ETF sold 305 shares of JANX on 2025-12-17. The shares were previously bought for an average price of USD 24.7281. The Janux Therapeutics Inc shares were sold for -43.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,242 The average price that the ETF previously sold JANX share for is USD 33.7799 which is higher than the selling price of USD 14.1 on 2025-12-17. |
| ARVN - Arvinas Inc | SELL | -375 @ USD 11.72 | USD -4,395 | The ETF sold 375 shares of ARVN on 2025-12-17. The shares were previously bought for an average price of USD 11.3626. The Arvinas Inc shares were sold for 3.1% higher than average price of previous purchases. This sale made a profit of USD 134 The average price that the ETF previously sold ARVN share for is USD 13.0027 which is higher than the selling price of USD 11.72 on 2025-12-17. |
| AMLX - Amylyx Pharmaceuticals Inc | SELL | -392 @ USD 11.87 | USD -4,653 | The ETF sold 392 shares of AMLX on 2025-12-17. The shares were previously bought for an average price of USD 13.5196. The Amylyx Pharmaceuticals Inc shares were sold for -12.2% lower than average price of previous purchases. This resulted in an overall loss of USD 647 The average price that the ETF previously sold AMLX share for is USD 10.5321 so the ETF has sold 392 shares on 2025-12-17 at a higher price than the previous selling average. |
| IART - Integra LifeSciences Holdings | SELL | -358 @ USD 13.04 | USD -4,668 | The ETF sold 358 shares of IART on 2025-12-17. The shares were previously bought for an average price of USD 20.1099. The Integra LifeSciences Holdings shares were sold for -35.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,531 The average price that the ETF previously sold IART share for is USD 18.5118 which is higher than the selling price of USD 13.04 on 2025-12-17. |
| 302440.KS - SK BIOSCIENCE LTD | SELL | -138 @ KRW 34.668 | KRW -4,784 | The ETF sold 138 shares of 302440.KS on 2025-12-17. The shares were previously bought for an average price of KRW 36.2275. The SK BIOSCIENCE LTD shares were sold for -4.3% lower than average price of previous purchases. This resulted in an overall loss of KRW 215 (USD $0) The average price that the ETF previously sold 302440.KS share for is KRW 31.2231 so the ETF has sold 138 shares on 2025-12-17 at a higher price than the previous selling average. |
| ASTH - Astrana Health Inc | SELL | -214 @ USD 22.64 | USD -4,845 | The ETF sold 214 shares of ASTH on 2025-12-17. The shares were previously bought for an average price of USD 26.5685. The Astrana Health Inc shares were sold for -14.8% lower than average price of previous purchases. This resulted in an overall loss of USD 841 The average price that the ETF previously sold ASTH share for is USD 33.842 which is higher than the selling price of USD 22.64 on 2025-12-17. |
| EVT.DE - Evotec SE | SELL | -799 @ EUR 6.07708 | EUR -4,856 | The ETF sold 799 shares of EVT.DE on 2025-12-17. The shares were previously bought for an average price of EUR 6.56761. The Evotec SE shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of EUR 392 (USD $461) The average price that the ETF previously sold EVT.DE share for is EUR 8.00909 which is higher than the selling price of EUR 6.07708 on 2025-12-17. |
| ONT.L - Oxford Nanopore Technologies Ltd | SELL | -3,045 @ GBP 1.67092 | GBP -5,088 | The ETF sold 3045 shares of ONT.L on 2025-12-17. The shares were previously bought for an average price of GBP 1.72772. The Oxford Nanopore Technologies Ltd shares were sold for -3.3% lower than average price of previous purchases. This resulted in an overall loss of GBP 173 (USD $232) The average price that the ETF previously sold ONT.L share for is GBP 1.61711 so the ETF has sold 3045 shares on 2025-12-17 at a higher price than the previous selling average. |
| 2252.HK - SHANGHAI MICROPORT MEDBOT CLASS H | SELL | -2,000 @ HKD 2.58366 | HKD -5,167 | The ETF sold 2000 shares of 2252.HK on 2025-12-17. The shares were previously bought for an average price of HKD 3.16268. The SHANGHAI MICROPORT MEDBOT CLASS H shares were sold for -18.3% lower than average price of previous purchases. This resulted in an overall loss of HKD 1,158 (USD $149) The average price that the ETF previously sold 2252.HK share for is HKD 2.73547 which is higher than the selling price of HKD 2.58366 on 2025-12-17. |
| ANAB - AnaptysBio Inc | SELL | -114 @ USD 45.69 | USD -5,209 | The ETF sold 114 shares of ANAB on 2025-12-17. The shares were previously bought for an average price of USD 23.8129. The AnaptysBio Inc shares were sold for 91.9% higher than average price of previous purchases. This sale made a profit of USD 2,494 The average price that the ETF previously sold ANAB share for is USD 21.5284 so the ETF has sold 114 shares on 2025-12-17 at a higher price than the previous selling average. |
| NVAX - Novavax Inc | SELL | -802 @ USD 6.53 | USD -5,237 | The ETF sold 802 shares of NVAX on 2025-12-17. The shares were previously bought for an average price of USD 6.53102. The Novavax Inc shares were sold for 0.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1 The average price that the ETF previously sold NVAX share for is USD 7.24109 which is higher than the selling price of USD 6.53 on 2025-12-17. |
| NVAX - Hana Microelectronics Public Company Limited | SELL | -802 @ USD 6.53 | USD -5,237 | The ETF sold 802 shares of NVAX on 2025-12-17. The shares were previously bought for an average price of USD 6.53102. The Hana Microelectronics Public Company Limited shares were sold for 0.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1 The average price that the ETF previously sold NVAX share for is USD 7.24109 which is higher than the selling price of USD 6.53 on 2025-12-17. |
| CDNA - Caredx Inc | SELL | -273 @ USD 19.49 | USD -5,321 | The ETF sold 273 shares of CDNA on 2025-12-17. The shares were previously bought for an average price of USD 19.212. The Caredx Inc shares were sold for 1.4% higher than average price of previous purchases. This sale made a profit of USD 76 The average price that the ETF previously sold CDNA share for is USD 19.5206 which is higher than the selling price of USD 19.49 on 2025-12-17. |
| SDGR - Schrodinger Inc | SELL | -307 @ USD 17.4 | USD -5,342 | The ETF sold 307 shares of SDGR on 2025-12-17. The shares were previously bought for an average price of USD 22.5384. The Schrodinger Inc shares were sold for -22.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,577 The average price that the ETF previously sold SDGR share for is USD 20.9068 which is higher than the selling price of USD 17.4 on 2025-12-17. |
| 4587.T - PeptiDream Inc. | SELL | -500 @ JPY 10.8091 | JPY -5,405 | The ETF sold 500 shares of 4587.T on 2025-12-17. The shares were previously bought for an average price of JPY 11.127. The PeptiDream Inc. shares were sold for -2.9% lower than average price of previous purchases. This resulted in an overall loss of JPY 159 (USD $1) The average price that the ETF previously sold 4587.T share for is JPY 10.7709 so the ETF has sold 500 shares on 2025-12-17 at a higher price than the previous selling average. |
| CERT - Certara Inc | SELL | -620 @ USD 8.86 | USD -5,493 | The ETF sold 620 shares of CERT on 2025-12-17. The shares were previously bought for an average price of USD 10.4074. The Certara Inc shares were sold for -14.9% lower than average price of previous purchases. This resulted in an overall loss of USD 959 The average price that the ETF previously sold CERT share for is USD 10.8863 which is higher than the selling price of USD 8.86 on 2025-12-17. |
| DYVOX.ST - | SELL | -543 @ SEK 10.2915 | SEK -5,588 | The ETF sold 543 shares of DYVOX.ST on 2025-12-17. The shares were previously bought for an average price of SEK 6.29712. The shares were sold for 63.4% higher than average price of previous purchases. This sale made a profit of SEK 2,169 (USD $233) The average price that the ETF previously sold DYVOX.ST share for is SEK 7.40512 so the ETF has sold 543 shares on 2025-12-17 at a higher price than the previous selling average. |
| 237690.KQ - ST Pharm Co.,Ltd. | SELL | -65 @ KRW 86.3659 | KRW -5,614 | The ETF sold 65 shares of 237690.KQ on 2025-12-17. The shares were previously bought for an average price of KRW 55.5458. The ST Pharm Co.,Ltd. shares were sold for 55.5% higher than average price of previous purchases. This sale made a profit of KRW 2,003 (USD $1) The average price that the ETF previously sold 237690.KQ share for is KRW 58.5783 so the ETF has sold 65 shares on 2025-12-17 at a higher price than the previous selling average. |
| RLAY - Relay Therapeutics Inc | SELL | -745 @ USD 8.03 | USD -5,982 | The ETF sold 745 shares of RLAY on 2025-12-17. The shares were previously bought for an average price of USD 5.08308. The Relay Therapeutics Inc shares were sold for 58.0% higher than average price of previous purchases. This sale made a profit of USD 2,195 The average price that the ETF previously sold RLAY share for is USD 3.89914 so the ETF has sold 745 shares on 2025-12-17 at a higher price than the previous selling average. |
| CSTL - Castle Biosciences Inc | SELL | -153 @ USD 39.66 | USD -6,068 | The ETF sold 153 shares of CSTL on 2025-12-17. The shares were previously bought for an average price of USD 21.3129. The Castle Biosciences Inc shares were sold for 86.1% higher than average price of previous purchases. This sale made a profit of USD 2,807 The average price that the ETF previously sold CSTL share for is USD 23.7329 so the ETF has sold 153 shares on 2025-12-17 at a higher price than the previous selling average. |
| PHARM.AS - Pharming Group NV | SELL | -3,688 @ EUR 1.6468 | EUR -6,073 | The ETF sold 3688 shares of PHARM.AS on 2025-12-17. The shares were previously bought for an average price of EUR 0.896789. The Pharming Group NV shares were sold for 83.6% higher than average price of previous purchases. This sale made a profit of EUR 2,766 (USD $3,250) The average price that the ETF previously sold PHARM.AS share for is EUR 0.9258 so the ETF has sold 3688 shares on 2025-12-17 at a higher price than the previous selling average. |
| PHM.MC - Pharma Mar SA | SELL | -71 @ EUR 85.9254 | EUR -6,101 | The ETF sold 71 shares of PHM.MC on 2025-12-17. The shares were previously bought for an average price of EUR 87.1976. The Pharma Mar SA shares were sold for -1.5% lower than average price of previous purchases. This resulted in an overall loss of EUR 90 (USD $106) The average price that the ETF previously sold PHM.MC share for is EUR 85.3157 so the ETF has sold 71 shares on 2025-12-17 at a higher price than the previous selling average. |
| 039200.KQ - Oscotec Inc. | SELL | -176 @ KRW 34.8707 | KRW -6,137 | The ETF sold 176 shares of 039200.KQ on 2025-12-17. The shares were previously bought for an average price of KRW 21.0043. The Oscotec Inc. shares were sold for 66.0% higher than average price of previous purchases. This sale made a profit of KRW 2,440 (USD $2) The average price that the ETF previously sold 039200.KQ share for is KRW 29.4851 so the ETF has sold 176 shares on 2025-12-17 at a higher price than the previous selling average. |
| BLFS - BioLife Solutions Inc | SELL | -248 @ USD 25.01 | USD -6,202 | The ETF sold 248 shares of BLFS on 2025-12-17. The shares were previously bought for an average price of USD 25.7305. The BioLife Solutions Inc shares were sold for -2.8% lower than average price of previous purchases. This resulted in an overall loss of USD 179 The average price that the ETF previously sold BLFS share for is USD 24.484 so the ETF has sold 248 shares on 2025-12-17 at a higher price than the previous selling average. |
| GLPG.AS - Galapagos NV | SELL | -200 @ EUR 31.5491 | EUR -6,310 | The ETF sold 200 shares of GLPG.AS on 2025-12-17. The shares were previously bought for an average price of EUR 29.0814. The Galapagos NV shares were sold for 8.5% higher than average price of previous purchases. This sale made a profit of EUR 494 (USD $580) The average price that the ETF previously sold GLPG.AS share for is EUR 26.7747 so the ETF has sold 200 shares on 2025-12-17 at a higher price than the previous selling average. |
| DVAX - Dynavax Technologies Corporation | SELL | -626 @ USD 10.79 | USD -6,755 | The ETF sold 626 shares of DVAX on 2025-12-17. The shares were previously bought for an average price of USD 12.6313. The Dynavax Technologies Corporation shares were sold for -14.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,153 The average price that the ETF previously sold DVAX share for is USD 11.2139 which is higher than the selling price of USD 10.79 on 2025-12-17. |
| NVCR - Novocure Ltd | SELL | -555 @ USD 12.33 | USD -6,843 | The ETF sold 555 shares of NVCR on 2025-12-17. The shares were previously bought for an average price of USD 16.4121. The Novocure Ltd shares were sold for -24.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,266 The average price that the ETF previously sold NVCR share for is USD 17.6527 which is higher than the selling price of USD 12.33 on 2025-12-17. |
| ZYME - Zymeworks Inc. Common Stock | SELL | -270 @ USD 25.59 | USD -6,909 | The ETF sold 270 shares of ZYME on 2025-12-17. The shares were previously bought for an average price of USD 17.6935. The Zymeworks Inc. Common Stock shares were sold for 44.6% higher than average price of previous purchases. This sale made a profit of USD 2,132 The average price that the ETF previously sold ZYME share for is USD 12.9216 so the ETF has sold 270 shares on 2025-12-17 at a higher price than the previous selling average. |
| 2162.HK - KEYMED BIOSCIENCES INC | SELL | -1,000 @ HKD 6.9926 | HKD -6,993 | The ETF sold 1000 shares of 2162.HK on 2025-12-17. The shares were previously bought for an average price of HKD 5.35965. The KEYMED BIOSCIENCES INC shares were sold for 30.5% higher than average price of previous purchases. This sale made a profit of HKD 1,633 (USD $210) The average price that the ETF previously sold 2162.HK share for is HKD 5.47753 so the ETF has sold 1000 shares on 2025-12-17 at a higher price than the previous selling average. |
| AXGN - Axogen Inc | SELL | -232 @ USD 31.39 | USD -7,282 | The ETF sold 232 shares of AXGN on 2025-12-17. The shares were previously bought for an average price of USD 18.047. The Axogen Inc shares were sold for 73.9% higher than average price of previous purchases. This sale made a profit of USD 3,096 The average price that the ETF previously sold AXGN share for is USD 15.3764 so the ETF has sold 232 shares on 2025-12-17 at a higher price than the previous selling average. |
| BIOA-B.ST - | SELL | -216 @ SEK 33.9749 | SEK -7,339 | The ETF sold 216 shares of BIOA-B.ST on 2025-12-17. The shares were previously bought for an average price of SEK 29.997. The shares were sold for 13.3% higher than average price of previous purchases. This sale made a profit of SEK 859 (USD $92) The average price that the ETF previously sold BIOA-B.ST share for is SEK 20.3803 so the ETF has sold 216 shares on 2025-12-17 at a higher price than the previous selling average. |
| 4887.T - Sawai Group Holdings Co., Ltd. | SELL | -500 @ JPY 15.0684 | JPY -7,534 | The ETF sold 500 shares of 4887.T on 2025-12-17. The shares were previously bought for an average price of JPY 13.195. The Sawai Group Holdings Co., Ltd. shares were sold for 14.2% higher than average price of previous purchases. This sale made a profit of JPY 937 (USD $6) The average price that the ETF previously sold 4887.T share for is JPY 12.8461 so the ETF has sold 500 shares on 2025-12-17 at a higher price than the previous selling average. |
| FTRE - Fortrea Holdings Inc. | SELL | -488 @ USD 16.19 | USD -7,901 | The ETF sold 488 shares of FTRE on 2025-12-17. The shares were previously bought for an average price of USD 10.5322. The Fortrea Holdings Inc. shares were sold for 53.7% higher than average price of previous purchases. This sale made a profit of USD 2,761 The average price that the ETF previously sold FTRE share for is USD 10.8269 so the ETF has sold 488 shares on 2025-12-17 at a higher price than the previous selling average. |
| 13.HK - HUTCHMED (CHINA) LTD | SELL | -3,000 @ HKD 2.64022 | HKD -7,921 | The ETF sold 3000 shares of 13.HK on 2025-12-17. The shares were previously bought for an average price of HKD 3.01399. The HUTCHMED (CHINA) LTD shares were sold for -12.4% lower than average price of previous purchases. This resulted in an overall loss of HKD 1,121 (USD $144) The average price that the ETF previously sold 13.HK share for is HKD 3.0869 which is higher than the selling price of HKD 2.64022 on 2025-12-17. |
| NEOG - Neogen Corporation | SELL | -1,135 @ USD 7.09 | USD -8,047 | The ETF sold 1135 shares of NEOG on 2025-12-17. The shares were previously bought for an average price of USD 9.99438. The Neogen Corporation shares were sold for -29.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,296 The average price that the ETF previously sold NEOG share for is USD 9.08647 which is higher than the selling price of USD 7.09 on 2025-12-17. |
| BCRX - BioCryst Pharmaceuticals Inc | SELL | -1,132 @ USD 7.13 | USD -8,071 | The ETF sold 1132 shares of BCRX on 2025-12-17. The shares were previously bought for an average price of USD 7.74854. The BioCryst Pharmaceuticals Inc shares were sold for -8.0% lower than average price of previous purchases. This resulted in an overall loss of USD 700 The average price that the ETF previously sold BCRX share for is USD 7.92728 which is higher than the selling price of USD 7.13 on 2025-12-17. |
| TNDM - Tandem Diabetes Care Inc | SELL | -362 @ USD 22.42 | USD -8,116 | The ETF sold 362 shares of TNDM on 2025-12-17. The shares were previously bought for an average price of USD 21.1386. The Tandem Diabetes Care Inc shares were sold for 6.1% higher than average price of previous purchases. This sale made a profit of USD 464 The average price that the ETF previously sold TNDM share for is USD 23.1693 which is higher than the selling price of USD 22.42 on 2025-12-17. |
| RCUS - Arcus Biosciences Inc | SELL | -386 @ USD 22.28 | USD -8,600 | The ETF sold 386 shares of RCUS on 2025-12-17. The shares were previously bought for an average price of USD 9.14068. The Arcus Biosciences Inc shares were sold for 143.7% higher than average price of previous purchases. This sale made a profit of USD 5,072 The average price that the ETF previously sold RCUS share for is USD 12.0876 so the ETF has sold 386 shares on 2025-12-17 at a higher price than the previous selling average. |
| HRMY - Harmony Biosciences Holdings | SELL | -231 @ USD 38.78 | USD -8,958 | The ETF sold 231 shares of HRMY on 2025-12-17. The shares were previously bought for an average price of USD 32.6637. The Harmony Biosciences Holdings shares were sold for 18.7% higher than average price of previous purchases. This sale made a profit of USD 1,413 The average price that the ETF previously sold HRMY share for is USD 32.4958 so the ETF has sold 231 shares on 2025-12-17 at a higher price than the previous selling average. |
| NEU.AX - | SELL | -688 @ AUD 13.1569 | AUD -9,052 | The ETF sold 688 shares of NEU.AX on 2025-12-17. The shares were previously bought for an average price of AUD 8.87049. The shares were sold for 48.3% higher than average price of previous purchases. This sale made a profit of AUD 2,949 (USD $1,956) The average price that the ETF previously sold NEU.AX share for is AUD 8.36845 so the ETF has sold 688 shares on 2025-12-17 at a higher price than the previous selling average. |
| TXG - 10X Genomics Inc | SELL | -576 @ USD 15.75 | USD -9,072 | The ETF sold 576 shares of TXG on 2025-12-17. The shares were previously bought for an average price of USD 12.5355. The 10X Genomics Inc shares were sold for 25.6% higher than average price of previous purchases. This sale made a profit of USD 1,852 The average price that the ETF previously sold TXG share for is USD 11.3564 so the ETF has sold 576 shares on 2025-12-17 at a higher price than the previous selling average. |
| TXG - Terex Corporation | SELL | -576 @ USD 15.75 | USD -9,072 | The ETF sold 576 shares of TXG on 2025-12-17. The shares were previously bought for an average price of USD 12.5355. The Terex Corporation shares were sold for 25.6% higher than average price of previous purchases. This sale made a profit of USD 1,852 The average price that the ETF previously sold TXG share for is USD 11.3564 so the ETF has sold 576 shares on 2025-12-17 at a higher price than the previous selling average. |
| 6951.T - JEOL Ltd. | SELL | -300 @ JPY 30.6579 | JPY -9,197 | The ETF sold 300 shares of 6951.T on 2025-12-17. The shares were previously bought for an average price of JPY 33.0489. The JEOL Ltd. shares were sold for -7.2% lower than average price of previous purchases. This resulted in an overall loss of JPY 717 (USD $5) The average price that the ETF previously sold 6951.T share for is JPY 32.4282 which is higher than the selling price of JPY 30.6579 on 2025-12-17. |
| STOK - Stoke Therapeutics Inc | SELL | -283 @ USD 32.86 | USD -9,299 | The ETF sold 283 shares of STOK on 2025-12-17. The shares were previously bought for an average price of USD 12.0607. The Stoke Therapeutics Inc shares were sold for 172.5% higher than average price of previous purchases. This sale made a profit of USD 5,886 The average price that the ETF previously sold STOK share for is USD 12.9189 so the ETF has sold 283 shares on 2025-12-17 at a higher price than the previous selling average. |
| 3933.HK - THE UNITED LABORATORIES INTERNATIO | SELL | -6,000 @ HKD 1.5502 | HKD -9,301 | The ETF sold 6000 shares of 3933.HK on 2025-12-17. The shares were previously bought for an average price of HKD 1.67688. The THE UNITED LABORATORIES INTERNATIO shares were sold for -7.6% lower than average price of previous purchases. This resulted in an overall loss of HKD 760 (USD $98) The average price that the ETF previously sold 3933.HK share for is HKD 1.6027 which is higher than the selling price of HKD 1.5502 on 2025-12-17. |
| CHEMM.CO - | SELL | -92 @ DKK 102.336 | DKK -9,415 | The ETF sold 92 shares of CHEMM.CO on 2025-12-17. The shares were previously bought for an average price of DKK 78.2284. The shares were sold for 30.8% higher than average price of previous purchases. This sale made a profit of DKK 2,218 (USD $349) The average price that the ETF previously sold CHEMM.CO share for is DKK 75.2163 so the ETF has sold 92 shares on 2025-12-17 at a higher price than the previous selling average. |
| KNSA - Kiniksa Pharmaceuticals Ltd | SELL | -228 @ USD 41.47 | USD -9,455 | The ETF sold 228 shares of KNSA on 2025-12-17. The shares were previously bought for an average price of USD 40.3374. The Kiniksa Pharmaceuticals Ltd shares were sold for 2.8% higher than average price of previous purchases. This sale made a profit of USD 258 The average price that the ETF previously sold KNSA share for is USD 35.6858 so the ETF has sold 228 shares on 2025-12-17 at a higher price than the previous selling average. |
| TWST - Twist Bioscience Corp | SELL | -297 @ USD 32.13 | USD -9,543 | The ETF sold 297 shares of TWST on 2025-12-17. The shares were previously bought for an average price of USD 36.2456. The Twist Bioscience Corp shares were sold for -11.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,222 The average price that the ETF previously sold TWST share for is USD 38.2961 which is higher than the selling price of USD 32.13 on 2025-12-17. |
| HLUN-B.CO - | SELL | -1,420 @ DKK 6.73326 | DKK -9,561 | The ETF sold 1420 shares of HLUN-B.CO on 2025-12-17. The shares were previously bought for an average price of DKK 6.0023. The shares were sold for 12.2% higher than average price of previous purchases. This sale made a profit of DKK 1,038 (USD $163) The average price that the ETF previously sold HLUN-B.CO share for is DKK 5.23511 so the ETF has sold 1420 shares on 2025-12-17 at a higher price than the previous selling average. |
| RXRX - Recursion Pharmaceuticals Inc | SELL | -2,077 @ USD 4.68 | USD -9,720 | The ETF sold 2077 shares of RXRX on 2025-12-17. The shares were previously bought for an average price of USD 5.14428. The Recursion Pharmaceuticals Inc shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 964 The average price that the ETF previously sold RXRX share for is USD 5.57265 which is higher than the selling price of USD 4.68 on 2025-12-17. |
| 9995.HK - REMEGEN LTD H | SELL | -1,000 @ HKD 9.96189 | HKD -9,962 | The ETF sold 1000 shares of 9995.HK on 2025-12-17. The shares were previously bought for an average price of HKD 9.70899. The REMEGEN LTD H shares were sold for 2.6% higher than average price of previous purchases. This sale made a profit of HKD 253 (USD $33) The average price that the ETF previously sold 9995.HK share for is HKD 4.20607 so the ETF has sold 1000 shares on 2025-12-17 at a higher price than the previous selling average. |
| DIA.MI - DiaSorin SpA | SELL | -136 @ EUR 75.2288 | EUR -10,231 | The ETF sold 136 shares of DIA.MI on 2025-12-17. The shares were previously bought for an average price of EUR 54.1257. The DiaSorin SpA shares were sold for 39.0% higher than average price of previous purchases. This sale made a profit of EUR 2,870 (USD $3,372) The average price that the ETF previously sold DIA.MI share for is EUR 107.757 which is higher than the selling price of EUR 75.2288 on 2025-12-17. |
| QDEL - Quidel Corporation | SELL | -350 @ USD 29.39 | USD -10,287 | The ETF sold 350 shares of QDEL on 2025-12-17. The shares were previously bought for an average price of USD 29.52. The Quidel Corporation shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of USD 45 The average price that the ETF previously sold QDEL share for is USD 32.631 which is higher than the selling price of USD 29.39 on 2025-12-17. |
| TECN.SW - | SELL | -67 @ CHF 155.686 | CHF -10,431 | The ETF sold 67 shares of TECN.SW on 2025-12-17. The shares were previously bought for an average price of CHF 197.12. The shares were sold for -21.0% lower than average price of previous purchases. This resulted in an overall loss of CHF 2,776 (USD $3,491) The average price that the ETF previously sold TECN.SW share for is CHF 206.309 which is higher than the selling price of CHF 155.686 on 2025-12-17. |
| ATRC - AtriCure Inc | SELL | -259 @ USD 40.81 | USD -10,570 | The ETF sold 259 shares of ATRC on 2025-12-17. The shares were previously bought for an average price of USD 33.402. The AtriCure Inc shares were sold for 22.2% higher than average price of previous purchases. This sale made a profit of USD 1,919 The average price that the ETF previously sold ATRC share for is USD 33.7032 so the ETF has sold 259 shares on 2025-12-17 at a higher price than the previous selling average. |
| NUVB - Nuvation Bio Inc | SELL | -1,279 @ USD 8.52 | USD -10,897 | The ETF sold 1279 shares of NUVB on 2025-12-17. The shares were previously bought for an average price of USD 6.64051. The Nuvation Bio Inc shares were sold for 28.3% higher than average price of previous purchases. This sale made a profit of USD 2,404 The average price that the ETF previously sold NUVB share for is USD 4.2693 so the ETF has sold 1279 shares on 2025-12-17 at a higher price than the previous selling average. |
| AUPH - Aurinia Pharmaceuticals Inc | SELL | -697 @ USD 15.79 | USD -11,006 | The ETF sold 697 shares of AUPH on 2025-12-17. The shares were previously bought for an average price of USD 11.2153. The Aurinia Pharmaceuticals Inc shares were sold for 40.8% higher than average price of previous purchases. This sale made a profit of USD 3,189 The average price that the ETF previously sold AUPH share for is USD 8.52725 so the ETF has sold 697 shares on 2025-12-17 at a higher price than the previous selling average. |
| CRVL - CorVel Corp | SELL | -156 @ USD 70.83 | USD -11,049 | The ETF sold 156 shares of CRVL on 2025-12-17. The shares were previously bought for an average price of USD 111.522. The CorVel Corp shares were sold for -36.5% lower than average price of previous purchases. This resulted in an overall loss of USD 6,348 The average price that the ETF previously sold CRVL share for is USD 136.23 which is higher than the selling price of USD 70.83 on 2025-12-17. |
| SRPT - Sarepta Therapeutics Inc | SELL | -527 @ USD 21.14 | USD -11,141 | The ETF sold 527 shares of SRPT on 2025-12-17. The shares were previously bought for an average price of USD 45.0034. The Sarepta Therapeutics Inc shares were sold for -53.0% lower than average price of previous purchases. This resulted in an overall loss of USD 12,576 The average price that the ETF previously sold SRPT share for is USD 67.7146 which is higher than the selling price of USD 21.14 on 2025-12-17. |
| BANB.SW - | SELL | -164 @ CHF 68.0889 | CHF -11,167 | The ETF sold 164 shares of BANB.SW on 2025-12-17. The shares were previously bought for an average price of CHF 65.0923. The shares were sold for 4.6% higher than average price of previous purchases. This sale made a profit of CHF 491 (USD $618) The average price that the ETF previously sold BANB.SW share for is CHF 67.3908 so the ETF has sold 164 shares on 2025-12-17 at a higher price than the previous selling average. |
| EKTA-B.ST - | SELL | -1,955 @ SEK 6.07695 | SEK -11,880 | The ETF sold 1955 shares of EKTA-B.ST on 2025-12-17. The shares were previously bought for an average price of SEK 5.63298. The shares were sold for 7.9% higher than average price of previous purchases. This sale made a profit of SEK 868 (USD $93) The average price that the ETF previously sold EKTA-B.ST share for is SEK 5.10951 so the ETF has sold 1955 shares on 2025-12-17 at a higher price than the previous selling average. |
| BAVA.CO - | SELL | -414 @ DKK 28.8917 | DKK -11,961 | The ETF sold 414 shares of BAVA.CO on 2025-12-17. The shares were previously bought for an average price of DKK 25.4205. The shares were sold for 13.7% higher than average price of previous purchases. This sale made a profit of DKK 1,437 (USD $226) The average price that the ETF previously sold BAVA.CO share for is DKK 25.8757 so the ETF has sold 414 shares on 2025-12-17 at a higher price than the previous selling average. |
| CGON - CG Oncology, Inc. Common stock | SELL | -325 @ USD 37.37 | USD -12,145 | The ETF sold 325 shares of CGON on 2025-12-17. The shares were previously bought for an average price of USD 41.6925. The CG Oncology, Inc. Common stock shares were sold for -10.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,405 The average price that the ETF previously sold CGON share for is USD 35.6201 so the ETF has sold 325 shares on 2025-12-17 at a higher price than the previous selling average. |
| ADPT - Adaptive Biotechnologies Corp | SELL | -798 @ USD 16.12 | USD -12,864 | The ETF sold 798 shares of ADPT on 2025-12-17. The shares were previously bought for an average price of USD 6.89362. The Adaptive Biotechnologies Corp shares were sold for 133.8% higher than average price of previous purchases. This sale made a profit of USD 7,363 The average price that the ETF previously sold ADPT share for is USD 8.32045 so the ETF has sold 798 shares on 2025-12-17 at a higher price than the previous selling average. |
| 326030.KS - SK BIOPHARMACEUTICALS LTD | SELL | -147 @ KRW 88.5285 | KRW -13,014 | The ETF sold 147 shares of 326030.KS on 2025-12-17. The shares were previously bought for an average price of KRW 77.4592. The SK BIOPHARMACEUTICALS LTD shares were sold for 14.3% higher than average price of previous purchases. This sale made a profit of KRW 1,627 (USD $1) The average price that the ETF previously sold 326030.KS share for is KRW 72.7431 so the ETF has sold 147 shares on 2025-12-17 at a higher price than the previous selling average. |
| BEAM - Beam Therapeutics Inc | SELL | -535 @ USD 25.6 | USD -13,696 | The ETF sold 535 shares of BEAM on 2025-12-17. The shares were previously bought for an average price of USD 18.6816. The Beam Therapeutics Inc shares were sold for 37.0% higher than average price of previous purchases. This sale made a profit of USD 3,701 The average price that the ETF previously sold BEAM share for is USD 21.0761 so the ETF has sold 535 shares on 2025-12-17 at a higher price than the previous selling average. |
| VRDN - Viridian Therapeutics Inc | SELL | -437 @ USD 32.13 | USD -14,041 | The ETF sold 437 shares of VRDN on 2025-12-17. The shares were previously bought for an average price of USD 30.1226. The Viridian Therapeutics Inc shares were sold for 6.7% higher than average price of previous purchases. This sale made a profit of USD 877 The average price that the ETF previously sold VRDN share for is USD 22.5994 so the ETF has sold 437 shares on 2025-12-17 at a higher price than the previous selling average. |
| SUPN - Supernus Pharmaceuticals Inc | SELL | -292 @ USD 48.75 | USD -14,235 | The ETF sold 292 shares of SUPN on 2025-12-17. The shares were previously bought for an average price of USD 36.2354. The Supernus Pharmaceuticals Inc shares were sold for 34.5% higher than average price of previous purchases. This sale made a profit of USD 3,654 The average price that the ETF previously sold SUPN share for is USD 34.7442 so the ETF has sold 292 shares on 2025-12-17 at a higher price than the previous selling average. |
| ACLX - Arcellx Inc | SELL | -220 @ USD 64.72 | USD -14,238 | The ETF sold 220 shares of ACLX on 2025-12-17. The shares were previously bought for an average price of USD 64.8725. The Arcellx Inc shares were sold for -0.2% lower than average price of previous purchases. This resulted in an overall loss of USD 34 The average price that the ETF previously sold ACLX share for is USD 72.343 which is higher than the selling price of USD 64.72 on 2025-12-17. |
| CPRX - Catalyst Pharmaceuticals Inc | SELL | -646 @ USD 24 | USD -15,504 | The ETF sold 646 shares of CPRX on 2025-12-17. The shares were previously bought for an average price of USD 22.4325. The Catalyst Pharmaceuticals Inc shares were sold for 7.0% higher than average price of previous purchases. This sale made a profit of USD 1,013 The average price that the ETF previously sold CPRX share for is USD 22.3939 so the ETF has sold 646 shares on 2025-12-17 at a higher price than the previous selling average. |
| IDYA - Ideaya Biosciences Inc | SELL | -463 @ USD 33.73 | USD -15,617 | The ETF sold 463 shares of IDYA on 2025-12-17. The shares were previously bought for an average price of USD 23.8167. The Ideaya Biosciences Inc shares were sold for 41.6% higher than average price of previous purchases. This sale made a profit of USD 4,590 The average price that the ETF previously sold IDYA share for is USD 22.185 so the ETF has sold 463 shares on 2025-12-17 at a higher price than the previous selling average. |
| VCYT - Veracyte Inc | SELL | -385 @ USD 42.21 | USD -16,251 | The ETF sold 385 shares of VCYT on 2025-12-17. The shares were previously bought for an average price of USD 34.3612. The Veracyte Inc shares were sold for 22.8% higher than average price of previous purchases. This sale made a profit of USD 3,022 The average price that the ETF previously sold VCYT share for is USD 33.9894 so the ETF has sold 385 shares on 2025-12-17 at a higher price than the previous selling average. |
| ACAD - ACADIA Pharmaceuticals Inc | SELL | -652 @ USD 26.93 | USD -17,558 | The ETF sold 652 shares of ACAD on 2025-12-17. The shares were previously bought for an average price of USD 20.1364. The ACADIA Pharmaceuticals Inc shares were sold for 33.7% higher than average price of previous purchases. This sale made a profit of USD 4,429 The average price that the ETF previously sold ACAD share for is USD 17.5289 so the ETF has sold 652 shares on 2025-12-17 at a higher price than the previous selling average. |
| LIVN - LivaNova PLC | SELL | -281 @ USD 63.08 | USD -17,725 | The ETF sold 281 shares of LIVN on 2025-12-17. The shares were previously bought for an average price of USD 46.485. The LivaNova PLC shares were sold for 35.7% higher than average price of previous purchases. This sale made a profit of USD 4,663 The average price that the ETF previously sold LIVN share for is USD 45.1071 so the ETF has sold 281 shares on 2025-12-17 at a higher price than the previous selling average. |
| SFZN.SW - | SELL | -209 @ CHF 90.3656 | CHF -18,886 | The ETF sold 209 shares of SFZN.SW on 2025-12-17. The shares were previously bought for an average price of CHF 123.569. The shares were sold for -26.9% lower than average price of previous purchases. This resulted in an overall loss of CHF 6,940 (USD $8,727) The average price that the ETF previously sold SFZN.SW share for is CHF 285.902 which is higher than the selling price of CHF 90.3656 on 2025-12-17. |
| LGND - Ligand Pharmaceuticals Incorporated | SELL | -101 @ USD 194.59 | USD -19,654 | The ETF sold 101 shares of LGND on 2025-12-17. The shares were previously bought for an average price of USD 126.392. The Ligand Pharmaceuticals Incorporated shares were sold for 54.0% higher than average price of previous purchases. This sale made a profit of USD 6,888 The average price that the ETF previously sold LGND share for is USD 119.256 so the ETF has sold 101 shares on 2025-12-17 at a higher price than the previous selling average. |
| SECT-B.ST - | SELL | -769 @ SEK 26.956 | SEK -20,729 | The ETF sold 769 shares of SECT-B.ST on 2025-12-17. The shares were previously bought for an average price of SEK 28.0136. The shares were sold for -3.8% lower than average price of previous purchases. This resulted in an overall loss of SEK 813 (USD $87) The average price that the ETF previously sold SECT-B.ST share for is SEK 28.8419 which is higher than the selling price of SEK 26.956 on 2025-12-17. |
| 298380.KQ - ABL Bio Inc. | SELL | -182 @ KRW 123.061 | KRW -22,397 | The ETF sold 182 shares of 298380.KQ on 2025-12-17. The shares were previously bought for an average price of KRW 40.1877. The ABL Bio Inc. shares were sold for 206.2% higher than average price of previous purchases. This sale made a profit of KRW 15,083 (USD $10) The average price that the ETF previously sold 298380.KQ share for is KRW 38.9291 so the ETF has sold 182 shares on 2025-12-17 at a higher price than the previous selling average. |
| TGTX - TG Therapeutics Inc | SELL | -751 @ USD 31.13 | USD -23,379 | The ETF sold 751 shares of TGTX on 2025-12-17. The shares were previously bought for an average price of USD 33.8235. The TG Therapeutics Inc shares were sold for -8.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,023 The average price that the ETF previously sold TGTX share for is USD 34.246 which is higher than the selling price of USD 31.13 on 2025-12-17. |
| LNTH - Lantheus Holdings Inc | SELL | -363 @ USD 65.24 | USD -23,682 | The ETF sold 363 shares of LNTH on 2025-12-17. The shares were previously bought for an average price of USD 76.9588. The Lantheus Holdings Inc shares were sold for -15.2% lower than average price of previous purchases. This resulted in an overall loss of USD 4,254 The average price that the ETF previously sold LNTH share for is USD 87.1645 which is higher than the selling price of USD 65.24 on 2025-12-17. |
| ALKS - Alkermes Plc | SELL | -862 @ USD 28.04 | USD -24,170 | The ETF sold 862 shares of ALKS on 2025-12-17. The shares were previously bought for an average price of USD 30.7179. The Alkermes Plc shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,308 The average price that the ETF previously sold ALKS share for is USD 29.4679 which is higher than the selling price of USD 28.04 on 2025-12-17. |
| 7747.T - Asahi Intecc Co., Ltd. | SELL | -1,300 @ JPY 19.3534 | JPY -25,159 | The ETF sold 1300 shares of 7747.T on 2025-12-17. The shares were previously bought for an average price of JPY 16.8906. The Asahi Intecc Co., Ltd. shares were sold for 14.6% higher than average price of previous purchases. This sale made a profit of JPY 3,202 (USD $21) The average price that the ETF previously sold 7747.T share for is JPY 15.9702 so the ETF has sold 1300 shares on 2025-12-17 at a higher price than the previous selling average. |
| MMS - LYXETFETUSITETFP | SELL | -294 @ USD 88.54 | USD -26,031 | The ETF sold 294 shares of MMS on 2025-12-17. The shares were previously bought for an average price of USD 75.2803. The LYXETFETUSITETFP shares were sold for 17.6% higher than average price of previous purchases. This sale made a profit of USD 3,898 The average price that the ETF previously sold MMS share for is USD 72.1725 so the ETF has sold 294 shares on 2025-12-17 at a higher price than the previous selling average. |
| 6869.T - Sysmex Corporation | SELL | -2,700 @ JPY 9.79572 | JPY -26,448 | The ETF sold 2700 shares of 6869.T on 2025-12-17. The shares were previously bought for an average price of JPY 14.9756. The Sysmex Corporation shares were sold for -34.6% lower than average price of previous purchases. This resulted in an overall loss of JPY 13,986 (USD $90) The average price that the ETF previously sold 6869.T share for is JPY 17.8391 which is higher than the selling price of JPY 9.79572 on 2025-12-17. |
| IPN.PA - Ipsen SA | SELL | -189 @ EUR 141.172 | EUR -26,682 | The ETF sold 189 shares of IPN.PA on 2025-12-17. The shares were previously bought for an average price of EUR 120.641. The Ipsen SA shares were sold for 17.0% higher than average price of previous purchases. This sale made a profit of EUR 3,880 (USD $4,559) The average price that the ETF previously sold IPN.PA share for is EUR 117.401 so the ETF has sold 189 shares on 2025-12-17 at a higher price than the previous selling average. |
| PRAX - Praxis Precision Medicines Inc | SELL | -107 @ USD 265.86 | USD -28,447 | The ETF sold 107 shares of PRAX on 2025-12-17. The shares were previously bought for an average price of USD 167.342. The Praxis Precision Medicines Inc shares were sold for 58.9% higher than average price of previous purchases. This sale made a profit of USD 10,541 The average price that the ETF previously sold PRAX share for is USD 141.138 so the ETF has sold 107 shares on 2025-12-17 at a higher price than the previous selling average. |
| AXSM - Axsome Therapeutics Inc | SELL | -200 @ USD 148 | USD -29,600 | The ETF sold 200 shares of AXSM on 2025-12-17. The shares were previously bought for an average price of USD 116.831. The Axsome Therapeutics Inc shares were sold for 26.7% higher than average price of previous purchases. This sale made a profit of USD 6,234 The average price that the ETF previously sold AXSM share for is USD 106.504 so the ETF has sold 200 shares on 2025-12-17 at a higher price than the previous selling average. |
| PTCT - PTC Therapeutics Inc | SELL | -412 @ USD 74.94 | USD -30,875 | The ETF sold 412 shares of PTCT on 2025-12-17. The shares were previously bought for an average price of USD 56.4444. The PTC Therapeutics Inc shares were sold for 32.8% higher than average price of previous purchases. This sale made a profit of USD 7,620 The average price that the ETF previously sold PTCT share for is USD 48.7105 so the ETF has sold 412 shares on 2025-12-17 at a higher price than the previous selling average. |
| BIM.PA - BioMerieux | SELL | -254 @ EUR 127.536 | EUR -32,394 | The ETF sold 254 shares of BIM.PA on 2025-12-17. The shares were previously bought for an average price of EUR 121.406. The BioMerieux shares were sold for 5.0% higher than average price of previous purchases. This sale made a profit of EUR 1,557 (USD $1,829) The average price that the ETF previously sold BIM.PA share for is EUR 123.044 so the ETF has sold 254 shares on 2025-12-17 at a higher price than the previous selling average. |
| BIO - Bio-Rad Laboratories Inc | SELL | -111 @ USD 301.28 | USD -33,442 | The ETF sold 111 shares of BIO on 2025-12-17. The shares were previously bought for an average price of USD 290.296. The Bio-Rad Laboratories Inc shares were sold for 3.8% higher than average price of previous purchases. This sale made a profit of USD 1,219 The average price that the ETF previously sold BIO share for is USD 268.747 so the ETF has sold 111 shares on 2025-12-17 at a higher price than the previous selling average. |
| BIO - Biotest Aktiengesellschaft | SELL | -111 @ USD 301.28 | USD -33,442 | The ETF sold 111 shares of BIO on 2025-12-17. The shares were previously bought for an average price of USD 290.296. The Biotest Aktiengesellschaft shares were sold for 3.8% higher than average price of previous purchases. This sale made a profit of USD 1,219 The average price that the ETF previously sold BIO share for is USD 268.747 so the ETF has sold 111 shares on 2025-12-17 at a higher price than the previous selling average. |
| RYTM - Rhythm Pharmaceuticals Inc | SELL | -302 @ USD 111.86 | USD -33,782 | The ETF sold 302 shares of RYTM on 2025-12-17. The shares were previously bought for an average price of USD 67.8137. The Rhythm Pharmaceuticals Inc shares were sold for 65.0% higher than average price of previous purchases. This sale made a profit of USD 13,302 The average price that the ETF previously sold RYTM share for is USD 63.8019 so the ETF has sold 302 shares on 2025-12-17 at a higher price than the previous selling average. |
| SRT3.DE - Sartorius AG | SELL | -132 @ EUR 277.994 | EUR -36,695 | The ETF sold 132 shares of SRT3.DE on 2025-12-17. The shares were previously bought for an average price of EUR 247.576. The Sartorius AG shares were sold for 12.3% higher than average price of previous purchases. This sale made a profit of EUR 4,015 (USD $4,718) The average price that the ETF previously sold SRT3.DE share for is EUR 240.662 so the ETF has sold 132 shares on 2025-12-17 at a higher price than the previous selling average. |
| 7701.T - Shimadzu Corporation | SELL | -1,500 @ JPY 27.769 | JPY -41,654 | The ETF sold 1500 shares of 7701.T on 2025-12-17. The shares were previously bought for an average price of JPY 26.4723. The Shimadzu Corporation shares were sold for 4.9% higher than average price of previous purchases. This sale made a profit of JPY 1,945 (USD $13) The average price that the ETF previously sold 7701.T share for is JPY 26.0858 so the ETF has sold 1500 shares on 2025-12-17 at a higher price than the previous selling average. |
| HALO - Halozyme Therapeutics Inc | SELL | -644 @ USD 65.77 | USD -42,356 | The ETF sold 644 shares of HALO on 2025-12-17. The shares were previously bought for an average price of USD 60.3305. The Halozyme Therapeutics Inc shares were sold for 9.0% higher than average price of previous purchases. This sale made a profit of USD 3,503 The average price that the ETF previously sold HALO share for is USD 54.8365 so the ETF has sold 644 shares on 2025-12-17 at a higher price than the previous selling average. |
| PME.AX - | SELL | -293 @ AUD 145.189 | AUD -42,540 | The ETF sold 293 shares of PME.AX on 2025-12-17. The shares were previously bought for an average price of AUD 165.183. The shares were sold for -12.1% lower than average price of previous purchases. This resulted in an overall loss of AUD 5,858 (USD $3,886) The average price that the ETF previously sold PME.AX share for is AUD 150.217 which is higher than the selling price of AUD 145.189 on 2025-12-17. |
| RGEN - Repligen Corporation | SELL | -274 @ USD 156.92 | USD -42,996 | The ETF sold 274 shares of RGEN on 2025-12-17. The shares were previously bought for an average price of USD 145.299. The Repligen Corporation shares were sold for 8.0% higher than average price of previous purchases. This sale made a profit of USD 3,184 The average price that the ETF previously sold RGEN share for is USD 135.2 so the ETF has sold 274 shares on 2025-12-17 at a higher price than the previous selling average. |
| 4523.T - Eisai Co., Ltd. | SELL | -1,500 @ JPY 29.0558 | JPY -43,584 | The ETF sold 1500 shares of 4523.T on 2025-12-17. The shares were previously bought for an average price of JPY 28.5269. The Eisai Co., Ltd. shares were sold for 1.9% higher than average price of previous purchases. This sale made a profit of JPY 793 (USD $5) The average price that the ETF previously sold 4523.T share for is JPY 28.5733 so the ETF has sold 1500 shares on 2025-12-17 at a higher price than the previous selling average. |
| TECH - Bio-Techne Corp | SELL | -819 @ USD 56.99 | USD -46,675 | The ETF sold 819 shares of TECH on 2025-12-17. The shares were previously bought for an average price of USD 59.3169. The Bio-Techne Corp shares were sold for -3.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,906 The average price that the ETF previously sold TECH share for is USD 58.9856 which is higher than the selling price of USD 56.99 on 2025-12-17. |
| DXCM - DexCom Inc | SELL | -757 @ USD 65.75 | USD -49,773 | The ETF sold 757 shares of DXCM on 2025-12-17. The shares were previously bought for an average price of USD 78.8148. The DexCom Inc shares were sold for -16.6% lower than average price of previous purchases. This resulted in an overall loss of USD 9,890 The average price that the ETF previously sold DXCM share for is USD 74.1271 which is higher than the selling price of USD 65.75 on 2025-12-17. |
| CRL - Creightons Plc | SELL | -256 @ USD 195.98 | USD -50,171 | The ETF sold 256 shares of CRL on 2025-12-17. The shares were previously bought for an average price of USD 165.907. The Creightons Plc shares were sold for 18.1% higher than average price of previous purchases. This sale made a profit of USD 7,699 The average price that the ETF previously sold CRL share for is USD 154.748 so the ETF has sold 256 shares on 2025-12-17 at a higher price than the previous selling average. |
| QIA.DE - QIAGEN NV | SELL | -1,132 @ EUR 45.2313 | EUR -51,202 | The ETF sold 1132 shares of QIA.DE on 2025-12-17. The shares were previously bought for an average price of EUR 43.4373. The QIAGEN NV shares were sold for 4.1% higher than average price of previous purchases. This sale made a profit of EUR 2,031 (USD $2,386) The average price that the ETF previously sold QIA.DE share for is EUR 43.1419 so the ETF has sold 1132 shares on 2025-12-17 at a higher price than the previous selling average. |
| RVTY - Revvity Inc. | SELL | -615 @ USD 96.77 | USD -59,514 | The ETF sold 615 shares of RVTY on 2025-12-17. The shares were previously bought for an average price of USD 100.003. The Revvity Inc. shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,988 The average price that the ETF previously sold RVTY share for is USD 96.6419 so the ETF has sold 615 shares on 2025-12-17 at a higher price than the previous selling average. |
| EXEL - Exelixis Inc | SELL | -1,424 @ USD 42 | USD -59,808 | The ETF sold 1424 shares of EXEL on 2025-12-17. The shares were previously bought for an average price of USD 38.1215. The Exelixis Inc shares were sold for 10.2% higher than average price of previous purchases. This sale made a profit of USD 5,523 The average price that the ETF previously sold EXEL share for is USD 38.7745 so the ETF has sold 1424 shares on 2025-12-17 at a higher price than the previous selling average. |
| LONN.SW - | SELL | -91 @ CHF 659.241 | CHF -59,991 | The ETF sold 91 shares of LONN.SW on 2025-12-17. The shares were previously bought for an average price of CHF 640.611. The shares were sold for 2.9% higher than average price of previous purchases. This sale made a profit of CHF 1,695 (USD $2,132) The average price that the ETF previously sold LONN.SW share for is CHF 663.451 which is higher than the selling price of CHF 659.241 on 2025-12-17. |
| ABT - Abbott Laboratories | SELL | -478 @ USD 126.71 | USD -60,567 | The ETF sold 478 shares of ABT on 2025-12-17. The shares were previously bought for an average price of USD 124.674. The Abbott Laboratories shares were sold for 1.6% higher than average price of previous purchases. This sale made a profit of USD 973 The average price that the ETF previously sold ABT share for is USD 128.966 which is higher than the selling price of USD 126.71 on 2025-12-17. |
| BSX - Boston Scientific Corporation | SELL | -646 @ USD 94.48 | USD -61,034 | The ETF sold 646 shares of BSX on 2025-12-17. The shares were previously bought for an average price of USD 97.6281. The Boston Scientific Corporation shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,034 The average price that the ETF previously sold BSX share for is USD 98.7059 which is higher than the selling price of USD 94.48 on 2025-12-17. |
| BSX - MULSTRXSSXIMETFP | SELL | -646 @ USD 94.48 | USD -61,034 | The ETF sold 646 shares of BSX on 2025-12-17. The shares were previously bought for an average price of USD 97.6281. The MULSTRXSSXIMETFP shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,034 The average price that the ETF previously sold BSX share for is USD 98.7059 which is higher than the selling price of USD 94.48 on 2025-12-17. |
| MRNA - Moderna Inc | SELL | -2,020 @ USD 30.51 | USD -61,630 | The ETF sold 2020 shares of MRNA on 2025-12-17. The shares were previously bought for an average price of USD 25.9653. The Moderna Inc shares were sold for 17.5% higher than average price of previous purchases. This sale made a profit of USD 9,180 The average price that the ETF previously sold MRNA share for is USD 30.2522 so the ETF has sold 2020 shares on 2025-12-17 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -215 @ USD 289.57 | USD -62,258 | The ETF sold 215 shares of PODD on 2025-12-17. The shares were previously bought for an average price of USD 282.956. The Insulet Corporation shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of USD 1,422 The average price that the ETF previously sold PODD share for is USD 292.793 which is higher than the selling price of USD 289.57 on 2025-12-17. |
| GH - Guardant Health Inc | SELL | -647 @ USD 97.47 | USD -63,063 | The ETF sold 647 shares of GH on 2025-12-17. The shares were previously bought for an average price of USD 54.9629. The Guardant Health Inc shares were sold for 77.3% higher than average price of previous purchases. This sale made a profit of USD 27,502 The average price that the ETF previously sold GH share for is USD 44.1029 so the ETF has sold 647 shares on 2025-12-17 at a higher price than the previous selling average. |
| 207940.KS - SAMSUNG BIOLOGICS LTD | SELL | -55 @ KRW 1182.63 | KRW -65,045 | The ETF sold 55 shares of 207940.KS on 2025-12-17. The shares were previously bought for an average price of KRW 760.081. The SAMSUNG BIOLOGICS LTD shares were sold for 55.6% higher than average price of previous purchases. This sale made a profit of KRW 23,240 (USD $16) The average price that the ETF previously sold 207940.KS share for is KRW 961.322 so the ETF has sold 55 shares on 2025-12-17 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -2,643 @ USD 25.04 | USD -66,181 | The ETF sold 2643 shares of PFE on 2025-12-17. The shares were previously bought for an average price of USD 24.3485. The Pfizer Inc shares were sold for 2.8% higher than average price of previous purchases. This sale made a profit of USD 1,828 The average price that the ETF previously sold PFE share for is USD 24.3682 so the ETF has sold 2643 shares on 2025-12-17 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -121 @ USD 556.86 | USD -67,380 | The ETF sold 121 shares of ISRG on 2025-12-17. The shares were previously bought for an average price of USD 536.021. The Intuitive Surgical Inc shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of USD 2,522 The average price that the ETF previously sold ISRG share for is USD 518.266 so the ETF has sold 121 shares on 2025-12-17 at a higher price than the previous selling average. |
| 068270.KS - CELLTRION INC | SELL | -540 @ KRW 125.021 | KRW -67,511 | The ETF sold 540 shares of 068270.KS on 2025-12-17. The shares were previously bought for an average price of KRW 121.694. The CELLTRION INC shares were sold for 2.7% higher than average price of previous purchases. This sale made a profit of KRW 1,797 (USD $1) The average price that the ETF previously sold 068270.KS share for is KRW 119.864 so the ETF has sold 540 shares on 2025-12-17 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,285 @ USD 53.55 | USD -68,812 | The ETF sold 1285 shares of BMY on 2025-12-17. The shares were previously bought for an average price of USD 53.3317. The Bloomsbury Publishing Plc shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 281 The average price that the ETF previously sold BMY share for is USD 50.6556 so the ETF has sold 1285 shares on 2025-12-17 at a higher price than the previous selling average. |
| MEDP - Medpace Holdings Inc | SELL | -125 @ USD 557.07 | USD -69,634 | The ETF sold 125 shares of MEDP on 2025-12-17. The shares were previously bought for an average price of USD 382.527. The Medpace Holdings Inc shares were sold for 45.6% higher than average price of previous purchases. This sale made a profit of USD 21,818 The average price that the ETF previously sold MEDP share for is USD 341.202 so the ETF has sold 125 shares on 2025-12-17 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -317 @ USD 222.63 | USD -70,574 | The ETF sold 317 shares of DHR on 2025-12-17. The shares were previously bought for an average price of USD 199.979. The Danaher Corporation shares were sold for 11.3% higher than average price of previous purchases. This sale made a profit of USD 7,180 The average price that the ETF previously sold DHR share for is USD 210.147 so the ETF has sold 317 shares on 2025-12-17 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -317 @ USD 222.63 | USD -70,574 | The ETF sold 317 shares of DHR on 2025-12-17. The shares were previously bought for an average price of USD 199.979. The Danaher Corporation shares were sold for 11.3% higher than average price of previous purchases. This sale made a profit of USD 7,180 The average price that the ETF previously sold DHR share for is USD 210.147 so the ETF has sold 317 shares on 2025-12-17 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -583 @ USD 121.36 | USD -70,753 | The ETF sold 583 shares of GILD on 2025-12-17. The shares were previously bought for an average price of USD 107.342. The Guild Esports Plc shares were sold for 13.1% higher than average price of previous purchases. This sale made a profit of USD 8,172 The average price that the ETF previously sold GILD share for is USD 106.154 so the ETF has sold 583 shares on 2025-12-17 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -219 @ USD 326.01 | USD -71,396 | The ETF sold 219 shares of AMGN on 2025-12-17. The shares were previously bought for an average price of USD 296.507. The Amgen Inc shares were sold for 10.0% higher than average price of previous purchases. This sale made a profit of USD 6,461 The average price that the ETF previously sold AMGN share for is USD 291.45 so the ETF has sold 219 shares on 2025-12-17 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -730 @ USD 98.3 | USD -71,759 | The ETF sold 730 shares of MDT on 2025-12-17. The shares were previously bought for an average price of USD 90.2193. The Medtronic PLC shares were sold for 9.0% higher than average price of previous purchases. This sale made a profit of USD 5,899 The average price that the ETF previously sold MDT share for is USD 86.8763 so the ETF has sold 730 shares on 2025-12-17 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -847 @ USD 84.84 | USD -71,859 | The ETF sold 847 shares of EW on 2025-12-17. The shares were previously bought for an average price of USD 74.591. The Edwards Lifesciences Corp shares were sold for 13.7% higher than average price of previous purchases. This sale made a profit of USD 8,681 The average price that the ETF previously sold EW share for is USD 72.9685 so the ETF has sold 847 shares on 2025-12-17 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -532 @ USD 136.66 | USD -72,703 | The ETF sold 532 shares of A on 2025-12-17. The shares were previously bought for an average price of USD 122.269. The Agilent Technologies Inc shares were sold for 11.8% higher than average price of previous purchases. This sale made a profit of USD 7,656 The average price that the ETF previously sold A share for is USD 122.177 so the ETF has sold 532 shares on 2025-12-17 at a higher price than the previous selling average. |
| NBIX - Neurocrine Biosciences Inc | SELL | -514 @ USD 141.7 | USD -72,834 | The ETF sold 514 shares of NBIX on 2025-12-17. The shares were previously bought for an average price of USD 127.74. The Neurocrine Biosciences Inc shares were sold for 10.9% higher than average price of previous purchases. This sale made a profit of USD 7,175 The average price that the ETF previously sold NBIX share for is USD 116.643 so the ETF has sold 514 shares on 2025-12-17 at a higher price than the previous selling average. |
| NOVN.SW - | SELL | -541 @ CHF 135.876 | CHF -73,509 | The ETF sold 541 shares of NOVN.SW on 2025-12-17. The shares were previously bought for an average price of CHF 113.545. The shares were sold for 19.7% higher than average price of previous purchases. This sale made a profit of CHF 12,081 (USD $15,193) The average price that the ETF previously sold NOVN.SW share for is CHF 111.802 so the ETF has sold 541 shares on 2025-12-17 at a higher price than the previous selling average. |
| HOLX - Hologic Inc | SELL | -986 @ USD 74.93 | USD -73,881 | The ETF sold 986 shares of HOLX on 2025-12-17. The shares were previously bought for an average price of USD 66.2934. The Hologic Inc shares were sold for 13.0% higher than average price of previous purchases. This sale made a profit of USD 8,516 The average price that the ETF previously sold HOLX share for is USD 66.6789 so the ETF has sold 986 shares on 2025-12-17 at a higher price than the previous selling average. |
| ROG.SW - | SELL | -187 @ CHF 399.094 | CHF -74,631 | The ETF sold 187 shares of ROG.SW on 2025-12-17. The shares were previously bought for an average price of CHF 324.411. The shares were sold for 23.0% higher than average price of previous purchases. This sale made a profit of CHF 13,966 (USD $17,563) The average price that the ETF previously sold ROG.SW share for is CHF 314.4 so the ETF has sold 187 shares on 2025-12-17 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -338 @ USD 224.31 | USD -75,817 | The ETF sold 338 shares of ABBV on 2025-12-17. The shares were previously bought for an average price of USD 201.245. The AbbVie Inc shares were sold for 11.5% higher than average price of previous purchases. This sale made a profit of USD 7,796 The average price that the ETF previously sold ABBV share for is USD 187.531 so the ETF has sold 338 shares on 2025-12-17 at a higher price than the previous selling average. |
| GSK.L - GlaxoSmithKline PLC | SELL | -3,151 @ GBP 24.568 | GBP -77,414 | The ETF sold 3151 shares of GSK.L on 2025-12-17. The shares were previously bought for an average price of GBP 19.3589. The GlaxoSmithKline PLC shares were sold for 26.9% higher than average price of previous purchases. This sale made a profit of GBP 16,414 (USD $22,036) The average price that the ETF previously sold GSK.L share for is GBP 18.4475 so the ETF has sold 3151 shares on 2025-12-17 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -789 @ USD 99.18 | USD -78,253 | The ETF sold 789 shares of MRK on 2025-12-17. The shares were previously bought for an average price of USD 80.8147. The Marks Electrical Group PLC shares were sold for 22.7% higher than average price of previous purchases. This sale made a profit of USD 14,490 The average price that the ETF previously sold MRK share for is USD 88.2321 so the ETF has sold 789 shares on 2025-12-17 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -789 @ USD 99.18 | USD -78,253 | The ETF sold 789 shares of MRK on 2025-12-17. The shares were previously bought for an average price of USD 80.8147. The Merck & Company Inc shares were sold for 22.7% higher than average price of previous purchases. This sale made a profit of USD 14,490 The average price that the ETF previously sold MRK share for is USD 88.2321 so the ETF has sold 789 shares on 2025-12-17 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -473 @ USD 172.1 | USD -81,403 | The ETF sold 473 shares of BIIB on 2025-12-17. The shares were previously bought for an average price of USD 130.477. The Biogen Inc shares were sold for 31.9% higher than average price of previous purchases. This sale made a profit of USD 19,688 The average price that the ETF previously sold BIIB share for is USD 141.15 so the ETF has sold 473 shares on 2025-12-17 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -410 @ USD 210.33 | USD -86,235 | The ETF sold 410 shares of JNJ on 2025-12-17. The shares were previously bought for an average price of USD 170.984. The Johnson & Johnson shares were sold for 23.0% higher than average price of previous purchases. This sale made a profit of USD 16,132 The average price that the ETF previously sold JNJ share for is USD 157.919 so the ETF has sold 410 shares on 2025-12-17 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -155 @ USD 562.56 | USD -87,197 | The ETF sold 155 shares of TMO on 2025-12-17. The shares were previously bought for an average price of USD 418.499. The Time Out Group plc shares were sold for 34.4% higher than average price of previous purchases. This sale made a profit of USD 22,329 The average price that the ETF previously sold TMO share for is USD 485.341 so the ETF has sold 155 shares on 2025-12-17 at a higher price than the previous selling average. |
| NTRA - Natera Inc | SELL | -388 @ USD 225.49 | USD -87,490 | The ETF sold 388 shares of NTRA on 2025-12-17. The shares were previously bought for an average price of USD 176.324. The Natera Inc shares were sold for 27.9% higher than average price of previous purchases. This sale made a profit of USD 19,076 The average price that the ETF previously sold NTRA share for is USD 165.005 so the ETF has sold 388 shares on 2025-12-17 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -401 @ USD 221.43 | USD -88,793 | The ETF sold 401 shares of IQV on 2025-12-17. The shares were previously bought for an average price of USD 162.435. The IQVIA Holdings Inc shares were sold for 36.3% higher than average price of previous purchases. This sale made a profit of USD 23,657 The average price that the ETF previously sold IQV share for is USD 178.175 so the ETF has sold 401 shares on 2025-12-17 at a higher price than the previous selling average. |
| GMAB.CO - | SELL | -280 @ DKK 317.628 | DKK -88,936 | The ETF sold 280 shares of GMAB.CO on 2025-12-17. The shares were previously bought for an average price of DKK 222.447. The shares were sold for 42.8% higher than average price of previous purchases. This sale made a profit of DKK 26,651 (USD $4,192) The average price that the ETF previously sold GMAB.CO share for is DKK 216.619 so the ETF has sold 280 shares on 2025-12-17 at a higher price than the previous selling average. |
| UCB.BR - UCB SA | SELL | -341 @ EUR 276.348 | EUR -94,235 | The ETF sold 341 shares of UCB.BR on 2025-12-17. The shares were previously bought for an average price of EUR 208.203. The UCB SA shares were sold for 32.7% higher than average price of previous purchases. This sale made a profit of EUR 23,237 (USD $27,303) The average price that the ETF previously sold UCB.BR share for is EUR 183.737 so the ETF has sold 341 shares on 2025-12-17 at a higher price than the previous selling average. |
| ILMN - Illumina Inc | SELL | -729 @ USD 129.56 | USD -94,449 | The ETF sold 729 shares of ILMN on 2025-12-17. The shares were previously bought for an average price of USD 95.299. The Illumina Inc shares were sold for 36.0% higher than average price of previous purchases. This sale made a profit of USD 24,976 The average price that the ETF previously sold ILMN share for is USD 102.174 so the ETF has sold 729 shares on 2025-12-17 at a higher price than the previous selling average. |
| EXAS - EXACT Sciences Corporation | SELL | -984 @ USD 101.61 | USD -99,984 | The ETF sold 984 shares of EXAS on 2025-12-17. The shares were previously bought for an average price of USD 62.0439. The EXACT Sciences Corporation shares were sold for 63.8% higher than average price of previous purchases. This sale made a profit of USD 38,933 The average price that the ETF previously sold EXAS share for is USD 53.6061 so the ETF has sold 984 shares on 2025-12-17 at a higher price than the previous selling average. |